This announcement is a separate document:
派林生物：派斯双林生物制药股份有限公司2022年第一季度业绩预告
Pailin Biotech: Pax Shuanglin Biopharmaceutical Co., Ltd. performance forecast for the first quarter of 2022
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.